Resources
White Papers, Videos & Webinars
White Papers
FDA Oncology Drug Approvals
Q1-2021
Q1-2021
FDA Oncology Drug Approvals
Q4-2020
Q4-2020
FDA Oncology Drug Approvals
Q3-2020
Q3-2020
FDA Oncology Drug Approvals
Q2-2020
Q2-2020
Is Prior Authorization the Best Approach for Oncology?
A Comparative Review of the Pros and Cons of Various Prior Authorization Approaches
A Comparative Review of the Pros and Cons of Various Prior Authorization Approaches
Oncology 2020: Key Challenges That Will Impact Health Plans
April 2020
April 2020
Data Sheets
Oncology Analytics
Company Overview
Company Overview
OneUM™ By Oncology Analytics
Unified e-Prior Authorization for Medical and Pharmacy Drugs
Unified e-Prior Authorization for Medical and Pharmacy Drugs
Oncology Insights Pro™ By Oncology Analytics
The right insights, paired with expert advisory services
The right insights, paired with expert advisory services
Pharmacy Consulting
Overview
Overview
Videos
Webinars
Tracking FDA Cancer Drug Approvals: Report on Q1 2021 Activity
June 30, 2021
1:00 PM EST
June 30, 2021
1:00 PM EST
Ask Us Anything: Answering Your Questions About Cost-Effective, Patient-First Cancer Care
Available On-Demand
Available On-Demand
Real-World Evidence in Oncology – Confirming the Treatment Landscape or Changing it?
Available On-Demand
Available On-Demand
Health Plan Best Practices for Using Oncology Pharmacy Expertise to Navigate the Anti-Cancer Drug Market
Available On-Demand
Available On-Demand
Is Prior Authorization the Best Approach for Oncology?
Available On-Demand
Available On-Demand